Global Latent Tuberculosis Infection LTBI Testing Market Overview And Scope:
Global Latent Tuberculosis Infection LTBI Testing Market Size was estimated at USD 1473.76 million in 2022 and is projected to reach USD 2026.78 million by 2028, exhibiting a CAGR of 5.45% during the forecast period.
The Global Latent Tuberculosis Infection LTBI Testing Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Latent Tuberculosis Infection LTBI Testing utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Qiagen, Sanofi, Oxford Immunotec, Thermo Fisher Scientific, Par Sterile, Bio-Rad Laboratories
Global Latent Tuberculosis Infection LTBI Testing Market Segmentation
By Type, Latent Tuberculosis Infection LTBI Testing market has been segmented into:Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Latent Tuberculosis Infection (LTBI)
By Application, Latent Tuberculosis Infection LTBI Testing market has been segmented into:
Hospitals and Clinics
Diagnostic Laboratories
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Latent Tuberculosis Infection LTBI Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Latent Tuberculosis Infection LTBI Testing market.
Top Key Players Covered in Latent Tuberculosis Infection LTBI Testing market are:
Qiagen
Sanofi
Oxford Immunotec
Thermo Fisher Scientific
Par Sterile
Bio-Rad Laboratories
Objective to buy this Report:
1. Latent Tuberculosis Infection LTBI Testing analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Latent Tuberculosis Infection LTBI Testing market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Latent Tuberculosis Infection LTBI Testing Market by Type
5.1 Latent Tuberculosis Infection LTBI Testing Market Overview Snapshot and Growth Engine
5.2 Latent Tuberculosis Infection LTBI Testing Market Overview
5.3 Tuberculin Skin Test (TST)
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Tuberculin Skin Test (TST): Geographic Segmentation
5.4 Interferon Gamma Released Assay (IGRA)
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Interferon Gamma Released Assay (IGRA): Geographic Segmentation
5.5 Latent Tuberculosis Infection (LTBI)
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Latent Tuberculosis Infection (LTBI): Geographic Segmentation
Chapter 6: Latent Tuberculosis Infection LTBI Testing Market by Application
6.1 Latent Tuberculosis Infection LTBI Testing Market Overview Snapshot and Growth Engine
6.2 Latent Tuberculosis Infection LTBI Testing Market Overview
6.3 Hospitals and Clinics
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals and Clinics: Geographic Segmentation
6.4 Diagnostic Laboratories
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Diagnostic Laboratories: Geographic Segmentation
6.5 Others
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Latent Tuberculosis Infection LTBI Testing Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Latent Tuberculosis Infection LTBI Testing Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Latent Tuberculosis Infection LTBI Testing Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 QIAGEN
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 SANOFI
7.4 OXFORD IMMUNOTEC
7.5 THERMO FISHER SCIENTIFIC
7.6 PAR STERILE
7.7 BIO-RAD LABORATORIES
Chapter 8: Global Latent Tuberculosis Infection LTBI Testing Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Tuberculin Skin Test (TST)
8.2.2 Interferon Gamma Released Assay (IGRA)
8.2.3 Latent Tuberculosis Infection (LTBI)
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospitals and Clinics
8.3.2 Diagnostic Laboratories
8.3.3 Others
Chapter 9: North America Latent Tuberculosis Infection LTBI Testing Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Tuberculin Skin Test (TST)
9.4.2 Interferon Gamma Released Assay (IGRA)
9.4.3 Latent Tuberculosis Infection (LTBI)
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospitals and Clinics
9.5.2 Diagnostic Laboratories
9.5.3 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Latent Tuberculosis Infection LTBI Testing Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Tuberculin Skin Test (TST)
10.4.2 Interferon Gamma Released Assay (IGRA)
10.4.3 Latent Tuberculosis Infection (LTBI)
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospitals and Clinics
10.5.2 Diagnostic Laboratories
10.5.3 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Latent Tuberculosis Infection LTBI Testing Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Tuberculin Skin Test (TST)
11.4.2 Interferon Gamma Released Assay (IGRA)
11.4.3 Latent Tuberculosis Infection (LTBI)
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospitals and Clinics
11.5.2 Diagnostic Laboratories
11.5.3 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Latent Tuberculosis Infection LTBI Testing Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Tuberculin Skin Test (TST)
12.4.2 Interferon Gamma Released Assay (IGRA)
12.4.3 Latent Tuberculosis Infection (LTBI)
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospitals and Clinics
12.5.2 Diagnostic Laboratories
12.5.3 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Latent Tuberculosis Infection LTBI Testing Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Tuberculin Skin Test (TST)
13.4.2 Interferon Gamma Released Assay (IGRA)
13.4.3 Latent Tuberculosis Infection (LTBI)
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospitals and Clinics
13.5.2 Diagnostic Laboratories
13.5.3 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Latent Tuberculosis Infection LTBI Testing Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Tuberculin Skin Test (TST)
14.4.2 Interferon Gamma Released Assay (IGRA)
14.4.3 Latent Tuberculosis Infection (LTBI)
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospitals and Clinics
14.5.2 Diagnostic Laboratories
14.5.3 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Latent Tuberculosis Infection LTBI Testing Scope:
|
Report Data
|
Latent Tuberculosis Infection LTBI Testing Market
|
|
Latent Tuberculosis Infection LTBI Testing Market Size in 2025
|
USD XX million
|
|
Latent Tuberculosis Infection LTBI Testing CAGR 2025 - 2032
|
XX%
|
|
Latent Tuberculosis Infection LTBI Testing Base Year
|
2024
|
|
Latent Tuberculosis Infection LTBI Testing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Qiagen, Sanofi, Oxford Immunotec, Thermo Fisher Scientific, Par Sterile, Bio-Rad Laboratories.
|
|
Key Segments
|
By Type
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Latent Tuberculosis Infection (LTBI)
By Applications
Hospitals and Clinics
Diagnostic Laboratories
Others
|
